Search Results

0 results for 'Novo Nordisk'

You can use to get even better search results
July 18, 2023 | The Legal Intelligencer

Partnering With In-House Counsel to Preserve Attorney-Client Privilege in Data Breach Probes

With the number of security incidents and data breaches drastically increasing each year, organizations often feel as though they are scrambling to protect their data and confidential information.
13 minute read
July 03, 2023 | Corporate Counsel

Job-Hopping Biotech Lawyers Losing Leverage as Funding Challenges Chill Sector

"Companies are not hiring at the same pace, for sure, and searches are taking longer to close, as companies are being a lot more introspective on who to hire," said Deb Thompson, a Major, Lindsey & Africa partner.
4 minute read
June 27, 2023 | Daily Report Online

Novo Nordisk Sues Weight Loss Company for Alleged False Statements About Ozempic, Other Drugs

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read
April 19, 2023 | National Law Journal

Covington Goes to Boston, as More Big Pharma Clients Relocate to City

The new office will be anchored by Megan Gates, who was chair of Mintz's corporate and securities practice.
3 minute read
April 11, 2023 | Litigation Daily

An Early Batch of Litigator of the Week Shout Outs—With a Twist

Here's a look at the big wins that came in during the Litigator of the Week cycle that passed while we were out.
7 minute read
April 07, 2023 | The Recorder

Fenwick, With New Client Capabilities, Grew Revenue Nearly 4% as Profits Inched Down

Revenue grew to $750.4 million, thanks to new regulatory capabilities and intellectual property growth, while profits fell 1.4% at Fenwick in 2022.
4 minute read
March 06, 2023 | Corporate Counsel

After Helping Sell Last Employer for $16B, Attorney Takes Legal Reins of Nerve-Repair Company

Axogen has hired Marc Began as general counsel. He most recently was legal chief of the medical device company Abiomed, which Johnson & Johnson bought for $16 billion.
2 minute read
March 02, 2023 | Corporate Counsel

Eli Lilly's Insulin Price Cut Not Likely to Extricate It From Legal Morass

"If a company has acquired or maintained monopoly power through anticompetitive means, they're liable under the antitrust laws whether or not they're exploiting their monopoly power by charging monopoly prices," said Daniel Crane, a professor at the University of Michigan Law School.
3 minute read
February 10, 2023 | Delaware Business Court Insider

After 3rd Circ. Ruling, Are 340B Drug Discount Cases SCOTUS Bound?

The statutory question at the center of the appeals could create a circuit split that brings the issue to the U.S. Supreme Court, said one court watcher.
7 minute read
February 10, 2023 | National Law Journal

SCOTUS Bound? After Appellate Ruling, What's Next in 340B Drug Discount Cases?

The statutory question at the center of the appeals could create a circuit split that brings the issue to the U.S. Supreme Court, said one court watcher.
7 minute read

TRENDING STORIES

    Resources